<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>6376977</identifier>
<setSpec>0210-5187</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Lasalvia, E</dc:author>
<dc:author>Vignale, R A</dc:author>
<dc:author>Borras, A</dc:author>
<dc:description xml:lang="en">The authors study three cytotoxicity system in psoriasis: direct cytotoxicity (DCC), antibodies mediated cytotoxicity (ADCC) and activated lymphocytes mediated cytotoxicity (PCC). The results of DCC and PCC are in the normal values, while ADCC are a somewhat increased, showing a hyperactivity of this system, which could explain some physiopathological phenomena of this disease. We consider this finding as secondary to an alteration of the immune system by dysbalance of B-T lymphocytes.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1984 </dc:date>
<dc:title xml:lang="es">Citotoxicidad en psoriasis.</dc:title>
<dc:title xml:lang="en">[Cytotoxicity in psoriasis].</dc:title>
<dc:publisher>Medicina cutanea ibero-latino-americana</dc:publisher>
</metadata>
</record>
</pubmed-document>
